March 5, 2024

 

U.S. Securities and Exchange Commission 

Division of Corporation Finance 

100 F Street, N.E. 

Washington, D.C. 20549

 

Attention: Chris Edwards

 

Re:	Apogee Therapeutics, Inc.
	Registration Statement on Form S-1 (File No. 333-277664)
	Request for Acceleration

 

Ladies and Gentlemen:

 

Pursuant to Rule 460 of the General Rules and Regulations under the Securities Act of 1933, as amended, please be advised that we will take reasonable steps to secure adequate distribution of the preliminary prospectus to underwriters, dealers, institutions and others, prior to the requested effective time of the Registration Statement.

 

We wish to advise you that the participating underwriters have informed us that they have complied and will continue to comply with the requirements of Rule 15c2-8 under the Securities Exchange Act of 1934, as amended.

 

We hereby join in the request of the registrant that the effectiveness of the above-captioned Registration Statement be accelerated to 4:00 p.m. Eastern Time, on Thursday, March 7, 2024 or as soon thereafter as practicable.

 

[Signature page follows]

 

 

Very truly yours,

 

JEFFERIES LLC 

BOFA SECURITIES, INC. 

GOLDMAN SACHS & CO. LLC 

cowen and company, llc 

STIFEL, NICOLAUS & COMPANY, INCORPORATED

 

As Representatives of the Underwriters

 

JEFFERIES LLC

 

By:	/s/ Matthew Kim
	Name:	Matthew Kim
	Title:	Managing Director
BOFA SECURITIES, INC.
By:	/s/ Cameron Taylor
	Name:	Cameron Taylor
	Title:	Managing Director
GOLDMAN SACHS & CO. LLC
By:	/s/ Elizabeth Reed
	Name:	Elizabeth Reed
	Title:	Managing Director
Cowen and company, llc
By:	/s/ Bill Follis
	Name:	Bill Follis
	Title:	Managing Director
STIFEL, NICOLAUS & COMPANY, INCORPORATED
By:	/s/ Nick Oust
	Name:	Nick Oust
	Title:	Managing Director

 

[Signature Page to Apogee Therapeutics, Inc. Acceleration Request]